1 Introduction

Generally, a mass is considered a primary retroperitoneal tumor (PRT) if it originates in the soft tissue, lymphatics, or nervous tissue of the retroperitoneal space, rather than being a solid organ [1]. Secondary lesions, cancer metastases and lymph node enlargement were excluded. Vascular anomalies may occur at various ages and in different organs, including the retroperitoneal region. According to the 2018 International Society for the Study of Vascular Anomalies (ISSVA) classification overview table, vascular anomalies are broadly classified into “vascular tumors”, involving abnormal proliferation of vascular endothelial cell, and “vascular malformations”, which are structural vascular abnormalities [2]. Vascular tumors can further be categorized into three groups: benign (e.g., infantile hemangioma, mentioned subsequently), locally aggressive or borderline (e.g., Kaposiform hemangioendothelioma), and malignant (e.g., angiosarcoma) [3]. Vascular tumors are uncommon in PRT, and the diagnosis becomes challenging when vascular tumors, along with other forms of tumors, are present in the retroperitoneal space rather than within an organ [4]. Infantile hemangiomas typically manifest on the skin’s surface. Superficial IHs, located in the upper dermis, appear as raised red papules, nodules, or plaques, while deep IHs extending into adipose tissue present as indistinctly bordered blue tumors [5]. Retroperitoneal infantile hemangioma (RIH) is extremely rare, with only four cases reported in English literature over the past two decades. This article presents a rare case of RIH. Additionally, we conduct a retrospective analysis of prior case reports and relevant literature, summarizing other lesions that require differentiation to enhance our understanding of this specific disease.

2 Case description

A 47-year-old male sought medical attention 3 months ago due to unexplained nausea and vomiting. He was diagnosed with gallstones and subsequently underwent cholecystectomy. A left retroperitoneal mass was discovered during a follow-up 2 months after gallstone surgery, leading the patient to seek care at our institution. Upon admission, the patient reported continued intermittent nausea and vomiting but denied experiencing chest tightness, chest pain, low back pain, as well as intestinal or urinary tract symptoms. The patient had no history of habitual drinking or smoking but had an 8-year history of hypertension and a 20-year history of hepatitis B. His mother was diagnosed with liver cirrhosis and hypertension. The results of laboratory and biochemical tests are presented in Table 1. Except for abnormal items and those of concern, all other items were within normal limits.

Table 1 Laboratory and biochemical tests

Computed tomography (CT) and Magnetic Resonance Imaging (MRI) can clearly reveal certain tumor contents, providing valuable insights to help refine the differential diagnosis [6]. On contrast-enhanced abdominal CT, a soft-tissue density shadow with irregular morphology measuring 3.2 cm × 2.0 cm was identified below the left renal pole, anterior to the psoas major muscle (Fig. 1A). Significant localized enhancement was observed in the arterial phase, with persistent enhancement in the venous phase and reduced enhancement in the delayed phase (Fig. 1B). MRI revealed an oval-shaped abnormal signal at the same location, displaying low signal in the T1-weighted image, high signal in T2 (long T1 and long T2 signals), high signal in T2-weighted compression fat image, high signal in DWI, and an unchanged ADC value (Fig. 1C). No significant abnormal signals were observed in the liver, gallbladder, spleen, tail of the pancreatic body, or left adrenal gland, and no definite enlarged lymph nodes were found. However, the evidence alone was insufficient to clarify the nature of the tumor. Combining the imaging features of the tumor with the patient's extensive history of hypertension, we suspected a paraganglioma. Following the evaluation of the patient's indicators, we opted for laparoscopic tumor resection. The laparoscopic-assisted mass excision was irregularly shaped and wrapped in adipose tissue (Fig. 2A). A grey-brown nodule with a firm texture and a cross-sectional size of approximately 2.7 cm × 1.2 cm was observed (Fig. 2B). Postoperative pathology (Fig. 3) samples and immunohistochemistry suggested that this was a primary capillary hemangioma (old term)/infantile hemangioma.

Fig. 1
figure 1

A Abdominal CT scan reveals a soft tissue density shadow measuring approximately 3.2 cm × 2.0 cm below the left lower pole of the kidney, anterior to the psoas major muscle. B Enhanced abdominal CT shows localized significant enhancement in the arterial phase. C Abdominal MRI displays an abnormal elliptical signal. CT computerized tomography, MRI Magnetic Resonance Imaging

Fig. 2
figure 2

A Gross view of the surgical resections. B Upon incision, a grey-brown nodule with a firm texture and a cross-sectional size of approximately 2.7 cm × 1.2 cm was observed

Fig. 3
figure 3

Intraoperative pathology sections were stained with hematoxylin and eosin (HE). The magnifications for (AC) were × 00, ×200, and ×400, respectively

2.1 Postoperative pathology

CD56 (+), Syn (−), CgA (−), S-100 (−), CD34 (vascular+), CD31 (vascular+), CD163 (scattered+), AE1/3 (−), Vim (+), EMA (−), NSE (−), SMA (+), Ki-67 (about1%+), CK7 (−), HMB45 (−), Inhibinα (−), CD117 (scattered+).

3 Discussion

In the latest ISSVA classification, vascular anomalies encompass vascular tumors and vascular malformations [2]. However, most prior literature did not rigorously classify these lesions according to ISSVA, making challenges in literature search and clinical management. Historically, they were commonly labeled as “hemangiomas” or “angiomas,” inaccurately encompassing non-infantile hemangiomas and certain vascular malformations. For instance, phrases like “cavernous hemangiomas” or “venous hemangiomas” used in the literature actually denote venous malformations rather than vascular tumors. The infantile hemangiomas (IHs) discussed in this article, primarily situated in the dermis and displaying a bright red color, were formerly denoted as capillary hemangiomas [7]. The ISSVA classification is an internationally recognized standard for categorizing vascular malformations. Using consistent terminology helps ensure accurate diagnosis and appropriate treatment for patients, while also minimizing diagnostic errors and improving scholarly communication by reducing confusion caused by inconsistent terminology [8, 9].

IHs typically manifest on the body surface, representing the most prevalent benign tumors in infancy that generally do not necessitate specific management. However, depending on their growth site, certain IHs may pose significant potential risks [7]. Notably, RIHs are exceedingly uncommon, with only four cases documented in the English literature over the past two decades [10,11,12,13]. The onset of these IHs in adults occurs, on average, at 56 years of age, and the maximum observed diameter of the mass has not exceeded 3 cm in each patient (Table 2). Due to the limited physique in infant patients, even a small mass may have the potential to invade surrounding organs. IHs should be considered in the differential diagnosis of unexplained lower gastrointestinal bleeding in neonates [12]. However, the retroperitoneal space is expansive in adults; thus, RIHs may not extensively involve surrounding organs, leading to a lack of significant symptoms. Moreover, many PRTs may remain asymptomatic in their early stages. Initial examinations often face challenges in associating an unidentified retroperitoneal mass with IHs based solely on patient symptoms and imaging. Complete excision of the mass is recommended, followed by postoperative pathology, to achieve a conclusive diagnosis. Moreover, surgical resection of all PRTs poses challenges due to the proximity of vital structures in the retroperitoneum and nearby blood vessels. These factors can impact local recurrence, postoperative outcomes, and long-term survival [14]. Therefore, a pathological biopsy becomes crucial for elucidating the nature of the mass. Aligning with insights from prior literature, it is crucial to distinguish RIHs from various other PRTs.

Table 2 Cases of retroperitoneal infantile hemangiomas reported in the English-language literature over the past 20 years and their characteristics

While the available laboratory evidence did not indicate catecholamine (CA) abnormalities, the patient’s enduring 8-year history of hypertension, the tumor’s location adjacent to the kidneys and urinary tract, and its distinctive imaging features led us to initially consider a paraganglioma (PGL). PGL originating outside the adrenal gland are uncommon catecholamine-secreting endocrine tumors. They are characterized by sudden or sustained hypertension, and excessive release of CA can induce severe cardiovascular manifestations, including Takotsubo cardiomyopathy, hypertensive crisis and acute myocardial infarction [15]. A pertinent family history of genetic disorders or PGL-related syndromes could assist in the diagnosis of PGL. The preferred test for identifying CA overdose is the 24-h urine or plasma free adrenaline test [16]. The imaging features include MRI with low or equal signal on T1-weighted imaging and high signal on T2-weighted imaging.

The diagnosis of postoperative pathology is also challenging due to certain similarities in the microscopic structure between IHs and anastomosing hemangiomas (AH). Montgomery and Epstein initially delineated this uncommon vascular tumor in 2009 [17]. Differing from IHs, AHs exhibit microscopic findings characterized by the occlusion of vascular channels, lined with a monolayer of occasionally pegged endothelial cells, interspersed with hyaline globules, and frequently associated with fibrin thrombi [18]. The primary involvement of AHs are within the genitourinary system, particularly demonstrating a predilection for the kidneys [19]. While AHs typically present as a substantial lesion, cystic formations may also be observed. According to previous literature, over 65% of cases were not exceed 3 cm in size, with a maximum of 14 cm [20]. The imaging characteristics, such as “well-defined, high or equal signal on T2-weighted imaging (T2 WI), equal signal on Diffusion-Weighted Imaging (DWI), and a marked progressive pattern of enhancement, possibly vascular enhancement,” can provide indications suggestive of AH[20].

Moreover, we suggest considering Kaposiform hemangioendothelioma (KHE) in the evaluation of suspected retroperitoneal vascular tumors in the future. KHE is a locally aggressive vascular tumor sharing histological morphology with Kaposi Sarcoma. Kasabach-Merritt phenomenon (KMP) occurs in some KHE patients, featuring profound and sustained thrombocytopenia, hypofibrinogenemia, consumptive coagulopathy, and elevated D-dimer levels [3]. Some patients with Tufted angioma (TA) also present with KMP. Although approximately 70% of KHE cases appears on the body surface, nearly 20% manifest in deeper regions, including the retroperitoneum [21, 22]. In instances where patients with retroperitoneal tumors exhibit KMP, clinicians should consider the possibility of KHE/TA (Table 3). However, no cases of retroperitoneal TA have been reported. Due to the deep infiltrative nature of KHE, it may not be discernible on ultrasound, while MRI is recommended for a comprehensive evaluation. The typical presentation involves poorly defined borders, multiplanar involvement, diffuse enhancement, adjacent fat strands in atypical locations, isointensity on T1-weighted imaging relative to adjacent muscle, and high signal on T2-weighted imaging.

Table 3 Differential diagnosis related to IH

Oral propranolol is now the first-line conservative treatment for IH. Hemangioma shrinkage is rapidly observed with oral propranolol. A large cohort study showed an average response rate of 96–98% after 6 months of therapy [5]. However, detecting and accurately diagnosing internally situated IHs, can present challenges for clinicians. It may hinder the timely development of an appropriate conservative treatment plan.

We posit that RIH should be considered in the differential diagnosis for adults presenting with retroperitoneal nodular enhancement on CT scans, particularly when the nodules are less than 3 cm in size and lack other significant symptoms or associated laboratory abnormalities.

4 Conclusion

We provide a case of RIH. RIHs are exceedingly rare primary retroperitoneal tumors. Diagnosing them in the initial stage poses challenges with ancillary tests. Conservative approaches without a definitive diagnosis are not recommended due to its specific location and diagnostic challenges. Considering the symptoms, potential malignancy must be eliminated, and a definitive diagnosis should be established through surgical resection and comprehensive pathological examination following detailed evaluation.